- NZ Newswire•5 days ago
Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.
We're sorry this is all we were able to find about this topic.
PEB.NZ: Summary for Pacific Edge Limited Ordinary S - Yahoo Finance
Pacific Edge Limited (PEB.NZ)
NZSE - NZSE Delayed price. Currency in NZD
Add to watchlist
|Day's range||0.58 - 0.59|
|52-week range||0.43 - 0.67|
|PE ratio (TTM)||-10.17|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|